Subscribe to RSS - ResMed

ResMed

ResMed connects vents to the cloud

‘It’s about time,’ says one HME provider
 - 
05/20/2016

SAN DIEGO – With Medicare stepping up scrutiny for vents, ResMed believes it has a way to keep them a viable business for HME providers.

ResMed connects vents

Up next: portable oxygen concentrators
 - 
05/17/2016

SAN DIEGO – ResMed already offers CPAP devices with cloud connectivity and soon it will offer life support ventilators with the same capabilities.

MACs remove ‘imminent death’ requirement for vents

 - 
05/13/2016

WASHINGTON – Recent guidance from the DME MACs on coverage criteria for ventilators is a move in the right direction, say industry stakeholders.

ITC accepts ResMed’s request to investigate

 - 
05/13/2016

SAN DIEGO – ResMed has announced that the U.S. International Trade Commission has accepted its request to investigate alleged infringement of its patented technology by Chinese manufacturer BMC Medical and its U.S. distributor, 3B Medical.

Stock movers: Invacare and ResMed

 - 
05/12/2016

Heartland Advisors has picked up 88,747 additional shares of Invacare stock, the firm disclosed in a report filed with the SEC on May 3. Heartland Advisors now holds about 3.6 million shares valued at about $39.95 million.

Integration begins for ResMed

Company acquired Inova, Brightree in less than three-month span
 - 
04/29/2016

SAN DIEGO – It’s still early days for recent acquisitions to impact ResMed’s financial results, but Inova Technologies helped to boost the company’s revenues by 2% in the third quarter of fiscal year 2016.

ResMed boosts revenue

 - 
04/27/2016

SAN DIEGO – ResMed reported revenues of $453.9 million for the three months ended March 31, 2016, a 7% increase compared to the same period in 2015. Net income for the quarter was $88.5 million, a 3% decrease compared to the same period in 2015.

Earnings season

 - 
Tuesday, April 26, 2016

It’s a busy week for those of us who cover the few public companies that do business in the home medical equipment market.

Stock movers: Ray Huggenberger, Mick Farrell

 - 
04/22/2016

Inogen CEO Ray Huggenberger sold more than half of his shares in the company in a transaction April 15. He sold 29,635 shares at an average price of $48.59 for a total value of $1.44 million.

In brief: OIG sticks to script, Aeroflow accepts chunk of contracts

 - 
04/15/2016

WASHINGTON – The Office of Inspector General has reiterated its recommendation that CMS match Medicaid reimbursement rates for HME to Medicare rates.

Pages